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Proteolytic processing of foamy virus Gag proteins appears to be different from that of other retroviruses. A single
carboxy-terminal cleavage site is consistently detectable in human foamy virus (HFV) Gag precursor protein p74Gag derived
from infected cells and/or purified virus particles. Using a recombinant HFV protease, we have determined the p74Gag
cleavage site that results in p70Gag and the carboxy-terminal p3Gag (Pfrepper et al., 1997, Biochem. Biophys. Res. Commun.
237, 548–553). To study the biological functions of p3Gag, proviral DNA clones were constructed coding for a carboxy-
terminally truncated p70Gag lacking the entire p3Gag protein. Removal of p3Gag resulted in an about 100-fold lower virus titer.
The expression of other HFV proteins and the processing of Pol proteins were indistinguishable from those of wild-type-
transfected cells. The defect in viral infectivity of the p3 mutants was partially restored by coexpressing the full-length p74Gag
protein in trans. The deletion of p3Gag resulted in particle assembly with wild-type virion morphology and encapsidation of
Pol proteins. Our data show that the carboxy-terminal p3Gag protein has an important function for viral infectivity but is not
required for preassembly of capsids, virus morphogenesis, and incorporation of Pol proteins into virions. © 1998 Academic Press
INTRODUCTION
Foamy viruses (FV) or spumaretroviruses constitute a
separate group within the family of Retroviridae. The
replication strategy of FVs has distinct aspects that are
different from that of other retroviruses (Coffin, 1996;
Lo¨chelt and Flu¨gel, 1995; Neumann-Haefelin et al., 1993;
Rethwilm, 1995; Yu et al., 1996;). FVs do not express their
Pro-Pol proteins (protease, PR; reverse transcriptase, RT;
RNase H, and integrase, IN) as part of a Gag-Pol precur-
sor but use instead a spliced pol transcript to express
the enzymatic functions independent of Gag (Bodem et
al., 1996; Enssle et al., 1996; Jordan et al., 1996; Lo¨chelt
and Flu¨gel, 1996; Yu et al., 1996). It has been postulated
that, as a consequence of the unique mechanism of
Pro-Pol expression, proteolytic processing of the p74Gag
precursor is inefficient, temporally delayed, or a combi-
nation of both (Giron et al., 1997; Winkler et al., 1997; Yu
et al., 1996). The HFV PR-mediated cleavage of p74Gag
that is consistently detectable in cell-associated and/or
cell-released Gag antigen is close to the carboxy termi-
nus of Gag; additional Gag cleavage products have also
been described (Bartholoma¨ et al., 1992; Enssle et al.,
1997; Hahn et al., 1994; Konvalinka et al., 1995; Lo¨chelt
and Flu¨gel, 1996; Morozov et al., 1997; Netzer et al.,
1990). Using a recombinant HFV PR, we have experimen-
tally determined the carboxy-terminal Gag cleavage site
to be SerArgAlaValAsn 2 ThrValThrGln (the vertical ar-
row represents the cleavage site between the peptide
bonds) consistent with predictions based on protein se-
quence alignments of known FV Gag sequences (Pfrep-
per et al., 1997; Winkler et al., 1997). In a recent study,
mutations were introduced into the carboxy terminus of
Gag close to the cleavage site. Some mutations inhibited
proteolytic cleavage at the terminal processing site,
whereas other mutations truncated Gag close to, but not
directly at, the authentic cleavage site (Enssle et al., 1997,
Fischer et al., 1998). Here we describe the phenotype of
HFV proviral clones that express a Gag protein specifi-
cally shortenend at the cleavage site. We show that the
p3Gag protein is essential for viral infectivity but dispens-
able for particle morphogenesis, morphology, and pack-
aging of Pol proteins into virions.
RESULTS
Removal of the p3Gag protein domain strongly
reduces HFV infectivity
To determine the biological role of the carboxy-termi-
nal p3Gag protein, this domain was deleted from HFV gag
by introducing two stop codons immediately down-
stream of the p3Gag cleavage site by site-directed mu-
tagenesis. Two independent clones designated pHSRVDp4
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(subclones 1 and 5) were shown to contain the mutations
introduced and were used throughout this study.
Two days after transfection of 10 mg of wt and each
p3-deleted proviral clone into permissive BHK-21 cells,
strong syncytia formation was observed independently
of whether the terminus of Gag had been deleted. After
low-speed centrifugation, cell culture supernatants were
used to determine viral infectivity on FAB cells (Yu and
Linial, 1993). Whereas wt pHSRV13-transfected cells
yielded a virus titer of about 1 3 105, the infectivity of
both p3 deletion mutants was repeatedly found to be 50-
to 100-fold lower. This result shows that the proteolytic
cleavage at the p3 site, p3Gag itself, or the full-length
p74Gag precursor has an important role for infectivity.
Previous studies showed that mutants having noncon-
servative amino acid changes close to the p3 processing
site were not infectious at all (Enssle et al., 1997).
Transcomplementation of pHSRVDp4 by full-length
HFV Gag
In order to transcomplement full infectivity of mutants
pHSRVDp4, the full-length authentic HFV p74Gag was
coexpressed from the eukaryotic expression construct
pBCgag in trans. Coexpression of 1 mg of either pHSRVDp4
mutant together with 9 mg of a wt HFV p74Gag expression
plasmid resulted in a clear increase in viral infectivity
when compared to cotransfections with pUC18 control
DNA (Table 1). However, cotransfections with the Gag
expression clone did not result in restoration of full
infectivity when compared to transfection of 1 mg of the
wt provirus pHSRV13 DNA.
Removal of the p3Gag protein does not alter HFV
gene expression
We next investigated whether the overall expression of
HFV genes and the proteolytic processing of Pro-Pol were
altered by deleting the terminal Gag sequences. For this
purpose, cell-associated antigens were analyzed by immu-
noblotting of cell extracts harvested 48 h after transfection
with pHSRVDp4, pHSRV13, and pUC18 control DNAs. Ali-
quots of cells transfected with similar efficiency were ana-
lyzed by immunoblotting. When a CA/NC-specific anti-
serum was used, clone pHSRVDp4 was found to express a
truncated 70-kDa Gag protein (Fig. 1A, lane 3, thin arrow)
that comigrated with the partially processed p70Gag protein
from wt pHSRV13-transfected cells (lane 2). As expected,
the p74Gag precursor (solid arrow) was not detectable in
cells transfected with pHSRVDp4, whereas it was clearly
visible in extracts from wt-transfected cells. There were no
TABLE 1
Transcomplementation of the Infectivity of HFV p3Gag Deletion
Mutants by Coexpression of the Full-Length HFV p74Gag Protein in
transa
2 days p.i.b 3 days p.i.b
pHSRV13 wt plus pUC18 4000 16,000
pHSRVDp4 plus pUC18 88 50
pHSRVDp4 plus pCMVGag 1875 530
a The HFV infectivity released from transfected cells was quantitated
as described under Materials and Methods using FAB indicator cells.
b Samples for titrations were taken 2 and 3 days after transfection, as
indicated.
FIG. 1. Deletion of the terminal Gag p3 protein does not influence HFV gene expression. Extracts from BHK-21 cells transfected with plasmids
pUC18 (lanes 1), pHSRV13 (lanes 2), and pHSRVDp4 (lanes 3) were harvested 48 h after transfection. Aliquots were subjected to immunoblotting using
HFV CA-NC (A)-, RNase H (B)-, and Bel 1/Bet (C)-specific antisera. The positions of the 74-kDa unprocessed Gag precursor (solid arrow, A), the p70Gag
(light arrow), the 127-kDa Pro-Pol precursor (arrowhead, B), the 80-kDa RT-RNase H (asterisk), and the 56-kDa Bet protein (diamond, C) are marked
at the right margins. Apparent sizes of prestained protein molecular mass markers are shown in kDa in the left margins.
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significant differences in the level of Gag expression when
comparing wt and p3-deleted provirus transfections. Ex-
tracts from pUC-transfected cells did not contain HFV-spe-
cific proteins.
When using antisera directed against the correspond-
ing HFV proteins, clones pHSRVDp4 (lanes 3) and
pHSRV13 (lanes 2) showed similar levels of protein ex-
pression and processing of Pro-Pol (Fig. 1B), Bel 1/Bet
(Fig. 1C), and Env (data not shown). This indicates that
the overall expression of HFV structural and bel genes
was not altered and that processing of Pro-Pol and Env
proteins was not changed by the deletion of the carboxy-
terminal p3Gag protein.
Removal of the p3Gag protein does not affect virus
morphology
We next studied the morphology of HFV particles in
cells transfected with wt and p3-deleted HFV provi-
ruses. Cells were grown for 2 days after transfection
on coverslips before processing for thin-section elec-
tron microscopy.
Under the electron microscope, pHSRV13 wt-trans-
fected cells revealed numerous small and large vacuoles
(spongy appearance). Several classes of virus particles
were identified. Within the dense cytoplasm and often
within the immediate vicinity of the nuclear membrane
(but not within the nucleus), large numbers of capsids
with a diameter of 40–50 nm were present. They were
sometimes organized into tightly packed clusters (not
shown) which resided outside the ER. Another indication
of these clusters being outside the ER was that the
individual capsids were only a few nanometer apart and
did not possess a membrane. Those virus particles that
had entered the ER were organized into rows, sheets, or
what seemed to be pairs (Fig. 2a). When clearly visible,
the viral membrane often enveloped multiple capsids
(see Fig. 2b). Within the ER, the viral membrane often
appeared smooth (Fig. 2a). However, the existence of a
clear lumen between viral and ER membrane (see Fig.
2b) seems indicative of the presence of a spiky coat. A
prominent, well-stained, spiky coat was observed in
those virus particles located in vacuoles of the spongy
cytoplasm (Fig. 2c) and especially when they were shed
into large cellular vacuoles (Fig. 2d) or into the medium
(not shown). Occasionally, however, a coat with a com-
plete set of spikes was absent (Figs. 2d and 2e). Inter-
estingly, even within the large vacuoles, virus particles
often occurred in pairs (Fig. 2d).
Similar to the control, cells transfected with the
pHSRVDp4 mutant showed the formation of spongy cy-
toplasm. Higher magnifications revealed virus particles
which were indistinguishable from the wt (Fig. 3a). As in
the control, clusters of capsids apparently lacking a
membrane were found within dense cellular cytoplasm
(Fig. 3b). Large individual virions with a distinct outer
membrane bearing Env proteins appeared in the spongy
cytoplasm but especially in the large intracellular vacu-
oles (Fig. 3a).
Removal of the p3Gag protein does not affect release
and composition of HFV particles
The removal of the p3Gag protein might interfere with
the release of viral particles and/or their composition.
To investigate this aspect, supernatants of transfec-
tions with wt pHSRV13 DNA and transfections of the
p3-deleted HFV provirus in the absence or the pres-
ence of coexpressed full-length HFV Gag were ana-
lyzed for HFV particles. Corresponding cell culture
supernatants were harvested 2 and 3 days after trans-
fection, cleared by low-speed centrifugation, layered
onto a 20% sucrose cushion, and centrifuged for 2 h at
76,000 g at 4°C. The resulting virus pellets were re-
suspended in protein sample buffer and subjected to
immunoblotting using the antisera described above.
To enhance the sensitivity of the detection system, the
immunoblots were developed with an enhanced che-
moluminescence system. Immunoblotting with the CA/
NC-specific antiserum showed that slightly lower
amounts of p70Gag were released from pHSRVDp4-
transfected cells (Fig. 4A, lanes 2 and 5) when com-
pared to the amount of p74 and p70Gag from pHSRV13-
transfected cells (Fig. 4A, lanes 1 and 4). As expected,
the HFV p74Gag precursor was absent from pHSRVDp4-
transfected cells, whereas low amounts of full-length
Gag were incorporated into viral particles when p74Gag
was provided in trans by a cotransfected HFV full-
length Gag expression plasmid (Fig. 4A, lanes 3 and
6). To analyze whether Pol and Env proteins are also
detectable in released wt and mutant viruses, immu-
noblots were performed with RNase H (Fig. 4B)- and
Env-specific (data not shown) antisera. RNase H-spe-
cific antigen corresponding to the 80-kDa PR-RT-
RNase H molecule was clearly detectable in cells from
p3-deleted transfections and wt transfections (Fig. 4B,
lanes 1 to 4 marked by an asterisk). The unprocessed
pre127Pro-Pol precursor was almost absent from puri-
fied virions, confirming that proteolytic processing of
Pro-Pol occured independently of whether p3 was
present. The uncleaved pre127Pro-Pol (arrowhead, Fig.
4B) was clearly present in cell-associated viral antigen
(lane at the left margin) but almost absent in virus
preparations (lanes 1 to 4). This indicates that the
one-step enrichment of virions was both efficient and
effective. In addition, the presence and the processing
of Env as part of released HFV particles was not
significantly affected by the Gag mutation (data not
shown). These results suggest that the p3Gag domain
either in the Gag precursor or by itself is not involved
in Pol processing and/or Pol and Env incorporation
into the virion.
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FIG. 2. Morphology of wt HFV 2 days after transfection of pHSRV13 DNA into BHK-21 cells. (a) Accumulation of virus particles, often within the vicinity
of a nuleus (n); capsids which often occur in pairs (arrowheads) are surrounded by membranes (arrows) indicating that they reside within the ER. (b) Pair
of capsids surrounded by a single viral membrane (large arrowhead) located within the lumen of the ER (small arrowheads indicate ER membrane). (c) Virus
particles with a very distinct coat of spikes (arrowheads) within the vacuoles of the spongy cytoplasm. (d) Budding and shedding of virus particles into a
large vacuole (v); again the particles seem to occur in pairs. (e) Budding of a virus into a vacuole of the spongy cytoplasm. The bar corresponds to 200 nm.
FIG. 3. Morphology of p3-deleted HFV 2 days after transfection of pHSRVDp4 DNA into BHK-21 cells. (a) Budding and shedding of virus particles
into a large vacuole (v); the outer membrane of most particles is decorated with prominent spikes (arrowheads); note the similarity to Fig. 2d; compare
also the small tightly packed cluster of capsids in the lower center of the figure. (b) Clusters of tightly packed capsids apparently lacking a membrane
within the dense cytoplasm of a transfected cell. The bar corresponds to 200 nm.
DISCUSSION
In this study we investigated the biological role of the
carboxy-terminal p3Gag protein for HFV gene expression,
infectivity, and virus morphogenesis and morphology.
Our data show that removal of the p3Gag moiety results in
a strong decrease in virus titer. In contrast, HFV gene
expression, proteolytic processing of the Pro-Pol precur-
sor protein, preassembly of viral capsids, and overall
virus morphology as well as virus release and incorpo-
ration of Pol and Env proteins were apparently not al-
tered or these changes were not detectable by the meth-
ods employed. In contrast to previous investigations on
HFV morphogenesis (Enssle et al., 1997; Fischer et al.,
1998), the p70Gag protein in our experimental system was
specifically terminated at its authentic cleavage site
(Pfrepper et al., 1997). Intentionally, we did not use het-
erologous overexpression systems to study HFV mor-
phology and morphogenesis as described previously
(Enssle et al., 1997; Fischer et al., 1997, 1998).
Our data indicate, that the carboxy-terminal domain of
the FV Gag precursor protein has a function either very
late during assembly and/or that this domain is critically
involved in functions required upon infection of new host
cells. Since virus release and particle composition
seemed unchanged, we favor the latter explanation. Re-
moval of the p3Gag protein does not prevent reverse
transcription of HFV proviral DNA species (data not
shown), in line with a previous report (Enssle et al., 1997).
It is tempting to speculate that information contained
within the short p3Gag sequence is required for penetra-
tion, disassembly, or proper functioning and targeting of
the preintegration complex. A recent study indicated that
proteolytic processing of Gag proteins takes place upon
infection of new host cells (Giron et al., 1997). It remains
to be seen whether the p3 domain may play a critical role
in this process. It is worth mentioning that released HFV
particles consist of a mixture of the full-length p74Gag and
the partially processed p70Gag proteins (Fischer et al.,
1998). Apparently, both Gag molecules have to be
present in virus particles for proper infectivity as sup-
ported by our trans-complementation studies (Table 1).
HFV particles consisting only of the Gag precursor ex-
hibited severe defects in virus morphology characterized
by significant size heterogeneity tending to oversized
and apparently labile particles (Konvalinka et al., 1995;
Fischer et al., 1998). This may be related to the fact that
particles consisting exclusively of p74Gag do not achieve
a wt curvature of the interacting Gag molecules to form
a closed spherical capsid shell with a defined size of
about 50 nm. The incorrect interactions of p74Gag mole-
cules in these mutant particles may allow only a lower
innner curvature of the forming capsid, causing the ab-
errant morphology observed as discussed for HIV (Fuller
et al., 1997). In contrast, our present study shows that
particles consisting exclusively of the authentic p70Gag
molecules preassemble and bud indistinguishably from
wt particles but have a severely reduced infectivity. The
loss of infectivity (Table 1) may be related to the fact that
the p70Gag particles have the correct size but are too
stable for efficient disassembly processes. Thus, a bal-
anced ratio of p70 and p74 Gag proteins or at least a
minimal amount of the full-length p74Gag may be required
for both proper assembly and disassembly (Table 1).
In another study, a heterologously overexpressed
p70Gag protein, terminated a few amino acid residues
upstream of the authentic p3 cleavage site, showed
also an apparently unaltered particle formation (Fi-
scher et al., 1998).
The function of the FV carboxy-terminal Gag domain is
probably distinct from the late (L) function of other retro-
viruses, since HFV particles devoid of p3Gag do not have
defects in release from cells as typical for L-domain
mutants of other retroviruses (reviewed by Craven and
Parent, 1996). Since p3-deleted particles exhibit wt levels
of Pol and Env proteins, the terminus of p74Gag is not
FIG. 4. Detection of HFV particles in cell culture supernatants of
transfected cells by immunoblotting. (A) BHK-21 cells were transfected
with pHSRV13 (lanes 1 and 4), pHSRVDp4 (lanes 2 and 5), and
pHSRVDp4 plus an HFV Gag expression plasmid (lanes 3 and 6). Cell
culture supernatants were harvested 2 days after transfection and virus
particles were purified by sedimentation through a sucrose cushion.
Identical aliquots of pelleted HFV particles were subjected to immuno-
blotting with an HFV CA/NC-specific antiserum. Cell-associated anti-
gen from HFV- and mock-infected HEL299 cells were used as controls.
The solid arrow indicates the position of the 74-kDa, the light arrow that
of the p70Gag proteins. The positions of marker proteins are given by
dots at the left margin of the blots: phosphorylase B, 111 kDa; bovine
serum albumin, 74 kDa; ovalbumin, 45 kDa (from top to bottom). (B)
BHK-21 cells were transfected with pHSRV13 (lane 1), pHSRVDp4 (lane
2), and pHSRVDp4 plus an HFV Gag expression plasmid (lanes 3 and
4). Cell culture supernatants were harvested 2 days after transfection
and virus particles were purified as above. Identical aliquots of pelleted
virus proteins were subjected to immunoblotting with an HFV RNase
H-specific antiserum. Cell-associated antigens from HFV- and mock-
infected HEL299 cells were used as controls. The arrowhead marks the
position of the 127-kDa Pro-Pol precursor and the asterisk that of the
80-kDa Pro-RT-RNase H proteins.
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required for packaging of Pro-Pol or incorporation of Env
proteins into the viral membrane and is also not a de-
terminant for the particle size, as recently identified for
Rous sarcoma virus (Krishna et al., 1998).
Further experiments will be required to determine the
function of the p3Gag that does not exhibit strong se-
quence conservation among the known FVs (Winkler et
al., 1997).
MATERIAL AND METHODS
Cells, virus, cell culture, and electroporation
Methods to propagate BHK-21 cells, to transfect them
with recombinant HFV proviral DNAs, and to determine the
HFV titer using the FAB titration assay have been described
previously (Lo¨chelt et al., 1991; Yu and Linial, 1993).
Construction of recombinant clones
For construction of specifically mutated HFV DNA
clones, standard methods in molecular biology were
employed (Sambrook et al., 1989). To construct an eu-
karyotic HFV p74Gag expression plasmid, HFV DNA se-
quences from nt 1223 to 3173 were amplified by PCR
using sense primer H1208s 59-GAAAGCTTAGCCACCAT-
GGCTTCA-39, antisense primer H3182a 59-GTGGGATC-
CCAATTTAGTCC-39, and Pfu polymerase as recom-
mended by the supplier (Stratagene, Heidelberg, Germa-
ny). The reaction product of about 1.9 kbp length was
digested with HindIII and BamHI and inserted into the
correspondingly digested expression vector pBC12CMV-
IL2 (Cullen, 1986). The identities of two independently
obtained HFV Gag expression clones, pBCgag2 and -7,
were verified by DNA sequencing.
To create an HFV DNA clone that has the capacity to
express the partially processed p70Gag protein, two
stop codons were introduced by PCR into gag directly
downstream of the carboxy-terminal Gag cleavage
site. For this purpose, PCR reactions using primers
2775s (Lo¨chelt and Flu¨gel, 1996) plus dp4a 59-GTG
TCTATCAATTGACAGCGCGTGAGTC-39 and dp4s 59-
GCTGTCAATTGATAGACACAGAGTGCCACGTC-39 (in-
troduced stop codons in boldface type) plus primer
3486a and pHSRV13 DNA as template were performed
as above (Lo¨chelt and Flu¨gel, 1996). The gel-purified
reaction products were combined and a third PCR with
primers 2775s and 3486a was performed. The reaction
product of about 700 nt contains two stop codons
directly downstream of the carboxy-terminal PR cleav-
age site in Gag (boldface letters in primer pd4s) and
was digested with SwaI and SapI and inserted into the
corresponding restriction enzyme sites of pHSRV13 by
a three component ligation. Recombinant clones were
analyzed by restriction analysis and DNA sequencing
and were found to correspond to the wild-type (wt) nt
sequence except for the mutations introduced.
Preparation and analyses of cell-associated and
released HFV antigen
Cell-associated HFV antigen was prepared and analyzed
by immunoblotting as described previously (Lo¨chelt et al.,
1991; Lo¨chelt and Flu¨gel, 1996). Released viral particles
were extracted from precleared cell culture supernatants
by sedimentation through a 20% sucrose cushion in 100
mM NaCl, 10 mM Tris/HCl, pH 7.4, 1 mM EDTA (wt/v) of 5 ml
in an SW28 rotor (Beckman, Munich, Germany) for 2 h at
24,000 rpm, 4°C. The sediment was resuspended in dou-
ble-concentrated protein sample buffer and analyzed by
immunoblotting. The monospecific polyclonal antisera di-
rected against defined domains of HFV structural and non-
structural proteins and methods used for protein transfer
and detection by chromogens and chemiluminescence
have been described previously (Lo¨chelt and Flu¨gel, 1996).
Cytology by electron microscopy
For conventional electron microscopy, cells grown on
coverslips were processed 2 days after transfection with
plasmid DNA. The cells were briefly rinsed with phos-
phate-buffered saline and then fixed with 1% glutaralde-
hyde and 4% formaldehyde in PIPES buffer (0.25 M
PIPES, pH 7.0) for 2 h. After three 15-min washes with the
same buffer, the cells were postfixed with 1% OsO4 in
PIPES buffer for 1 h. The cells were then washed again
with buffer and dehydrated in a graded ethanol series
followed by embedding in Spurr’s low-viscosity resin.
After thin sectioning, samples were stained with uranyl
acetate and lead citrate. Micrographs were taken on a
Philips EM400 electron microscope.
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